Shen K
Peking Union Medical College Hospital.
Zhonghua Fu Chan Ke Za Zhi. 1993 Apr;28(4):227-9, 254.
This article presents 19 patients with double primary carcinoma of the uterine corpus and ovary diagnosed and treated at Queen Mary Hospital, University of Hong Kong in last ten years. 14 patients had typical endometrial adenocarcinoma and endometrioid carcinoma of the ovary (group A), 5 had non-endometrioid carcinoma in the uterine corpus and/or ovary (group B). There is no significant difference in survival rate in group A and B (78.6% and 80%, respectively, mean follow-up 42 months), but the total survival rate in our series is 78%, which is equal to stage I ovarian cancer. The tumor grade and positive abdominal washing were proven to be statistically significant indicators of the poor prognosis (P < 0.05). The result reveals that the prognosis of double primary carcinoma of the uterine corpus and ovary is better and it is necessary to distinguish double primary carcinoma of the uterine corpus and ovary from stage II ovarian cancer and stage III endometrial carcinoma.
本文介绍了香港大学玛丽医院在过去十年中诊断和治疗的19例子宫体和卵巢双原发性癌患者。14例患者患有典型的子宫内膜腺癌和卵巢子宫内膜样癌（A组），5例患者子宫体和/或卵巢患有非子宫内膜样癌（B组）。A组和B组的生存率无显著差异（分别为78.6%和80%，平均随访42个月），但我们系列研究中的总生存率为78%，与I期卵巢癌相当。肿瘤分级和腹腔冲洗液阳性被证明是预后不良的统计学显著指标（P<0.05）。结果表明，子宫体和卵巢双原发性癌的预后较好，有必要将子宫体和卵巢双原发性癌与II期卵巢癌和III期子宫内膜癌区分开来。
